Inigo Vega
Analyst, Jefferies
Replay available
Bladex, Inc. Class E (NYSE: BLX) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.

Analyst, Jefferies
Analyst, BTG Pactual
Head of Treasury
Analyst, Credit Corp Capital
Analyst, Itaú
Analyst, Santander
Chief Executive Officer
Good morning, ladies and gentlemen, and welcome to Bladex's third quarter 2025 earnings conference call. A slide presentation is accompanying today's webcast and is also available in the investor relations section of the company's website, www.bladex.com. There will be an opportunity for you to ask questions at the end of today's presentation. Please note that today's conference call is being recorded. As a reminder, all participants will be in listen-only mode. I will now like to turn the call over to Mr. Jorge Salas, Chief Executive Officer. Sir, please go ahead. Good morning everyone and thank you for joining us to discuss our third quarter results. I'll start with the quarter's highlights, and then Annette will walk you through the financials in detail. After that, I'll briefly comment on the region's economic outlook and also provide an update on the implementation status of the two main IT platforms that underpin our path towards scalability and enhanced fee generation. After that, we will open the call for questions. Despite the more challenging environment marked by rate cuts, high regional liquidity, and wide open capital markets for Latin American issuers, at historically tight spreads, we delivered very solid results in the third quarter, fully aligned with our expectations and guidance. And I'm particularly proud of the fact that in mid-September, we successfully issued our first additional tier one capital instrument. The deal was led by JP Morgan and Bank of America as joint book runners and was more than three times oversubscribed. It attracted investors across Latin America, the United States, Canada, Europe, and the Middle East. I want to recognize Annette, our CFO, for her leadership in this landmark transaction for Blavix. Annette will cover the de...